Rankings
▼
Calendar
VCEL Q3 2023 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$46M
+18.2% YoY
Gross Profit
$31M
67.2% margin
Operating Income
-$5M
-11.1% margin
Net Income
-$4M
-8.0% margin
EPS (Diluted)
$-0.08
QoQ Revenue Growth
-0.7%
Cash Flow
Operating Cash Flow
$7M
Free Cash Flow
$600,000
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$318M
Total Liabilities
$114M
Stockholders' Equity
$204M
Cash & Equivalents
$60M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$46M
$39M
+18.2%
Gross Profit
$31M
$25M
+21.3%
Operating Income
-$5M
-$7M
+25.5%
Net Income
-$4M
-$7M
+44.4%
Revenue Segments
MACI Implants And Kits
$38M
100%
← FY 2023
All Quarters
Q4 2023 →